Roche Diagnostics Corp.is bullish about the prospects of liquid biopsies both as a tool to remake cancer treatment monitoring and diagnostics, but also, in particular, to improve cancer trial clinical trials.
In an interview with The Gray Sheet, Walter Koch, a vice president and head of research of Roche's molecular diagnostics...